Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/21232120

Download in:

View as

General Info

PMID
21232120